Anaemia and quality of life in chronic kidney disease: a consensus document from the European Anaemia of CKD Alliance.
慢性腎病中的貧血與生活品質:來自歐洲CKD貧血聯盟的共識文件。
Clin Kidney J 2024-08-13
Erythropoietin-Stimulating Agent Hyporesponsiveness in Patients Living with Chronic Kidney Disease.
慢性腎臟病患者中促紅細胞生成素刺激劑不敏感性。
Kidney Dis (Basel) 2022-07-16
Quality of life: a crucial aspect for the patients, a neglected goal in the treatment of anemia in patients with CKD.
生活品質:對患者至關重要的一個方面,在慢性腎臟病患者貧血治療中被忽略的目標。
Kidney Int 2023-05-24
The anaemia treatment journey of CKD patients: from epoetins to hypoxia-inducible factor-prolyl hydroxylase inhibitors.
慢性腎臟病患者的貧血治療之旅:從紅細胞生成素到缺氧誘導因子-脯氨酸羟化酶抑制劑。
Clin Kidney J 2023-10-03
Unresolved aspects in the management of renal anemia, a Delphi consensus of the Anemia Group of the S.E.N.
腎性貧血管理中未解決的問題:西班牙腎臟病學會貧血小組的 Delphi 共識。
Nefrologia (Engl Ed) 2024-01-30
Iron Supplements Concomitant within Hypoxia-Inducible Factor Prolyl Hydroxylase Domain Inhibitors in the Treatment of Chronic Kidney Disease Anemia.
慢性腎臟病貧血治療中與缺氧誘導因子脯氨酸羟化酶區域抑制劑同時使用的鐵補充劑。
Kidney Dis (Basel) 2023-12-16
A novel scenario in the therapeutic management of anemia of chronic kidney disease: placement and use of roxadustat.
慢性腎臟病貧血治療管理中的新情境:羅沙度胺的植入和使用。
J Nephrol 2024-01-08
Hypoxia-inducible factor prolyl hydroxylase inhibitors for anaemia in chronic kidney disease: a document by the European Renal Best Practice board of the European Renal Association.
慢性腎臟病貧血的缺氧誘導因子脯氫化酶抑制劑:歐洲腎臟最佳實踐委員會文件。
Nephrol Dial Transplant 2024-04-04
Stabilizing Hypoxia-Inducible Factor to Manage Anemia in Chronic Kidney Disease: From Basic Theory to Clinical Study.
穩定低氧誘導因子以管理慢性腎臟病貧血:從基本理論到臨床研究。
Kidney Dis (Basel) 2024-04-25